iNOs-IN-6 is an anti-inflammatory agent known for inhibiting the expression of NF-kappaB, iNOS, and MAPK with an IC50 ranging from 0.2 to 0.62 µM. Additionally, it decreases the levels of pro-inflammatory mediators, such as IL-6, TNF-alpha, and IL-1beta, with an IC50 ranging from 0.4 to 0.69 µM.
Target:
NO Synthase|||NF-kappaB|||Interleukin|||p38 MAPK
* VAT and and shipping costs not included. Errors and price changes excepted
